Intervention Review

Methotrexate for high-grade osteosarcoma in children and young adults

  1. Elvira C van Dalen1,*,
  2. Jorrit W van As2,
  3. Beatriz de Camargo3

Editorial Group: Cochrane Childhood Cancer Group

Published Online: 11 MAY 2011

Assessed as up-to-date: 24 MAR 2011

DOI: 10.1002/14651858.CD006325.pub3


How to Cite

van Dalen EC, van As JW, de Camargo B. Methotrexate for high-grade osteosarcoma in children and young adults. Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD006325. DOI: 10.1002/14651858.CD006325.pub3.

Author Information

  1. 1

    Emma Children's Hospital / Academic Medical Center, Department of Paediatric Oncology, Amsterdam, Netherlands

  2. 2

    Emma Children's Hospital / Academic Medical Center, c/o Cochrane Childhood Cancer Group, Amsterdam, Netherlands

  3. 3

    Centro de Pesquisa, Instituto Nacional do Cancer, Pediatric Hematology-Oncology Program, Rio de Janeiro, RJ, Brazil

*Elvira C van Dalen, Department of Paediatric Oncology, Emma Children's Hospital / Academic Medical Center, PO Box 22660 (room TKsO-247), Amsterdam, 1100 DD, Netherlands. e.c.vandalen@amc.uva.nl.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 11 MAY 2011

SEARCH

  1. Current Version

    Methotrexate for high-grade osteosarcoma in children and young adults

    Elvira C van Dalen, Jorrit W van As and Beatriz de Camargo

    Article first published online: 11 MAY 2011 | DOI: 10.1002/14651858.CD006325.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Methotrexate for high-grade osteosarcoma in children and young adults

    Elvira C van Dalen and Beatriz de Camargo

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD006325.pub2

  2. Version 1

    Methotrexate for high-grade osteosarcoma in children and young adults

    B De Camargo, H Van den Berg and EC Van Dalen

    Article first published online: 24 JAN 2007 | DOI: 10.1002/14651858.CD006325